ACHIEVE LIFE SCIENCES INC. - COMMON SHARES

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

09 Dec 2024 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA

03 Dec 2024 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

14 Nov 2024 08:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update

07 Nov 2024 16:05:01 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024

24 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting

23 Oct 2024 08:00:01 By Nasdaq GlobeNewswire

Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline

16 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting

10 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs

01 Oct 2024 08:46:16 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors

26 Aug 2024 16:30:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update

13 Aug 2024 16:01:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence

31 Jul 2024 08:00:06 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank

29 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024

25 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024

09 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes

01 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes

29 May 2024 08:00:01 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting

17 May 2024 08:00:29 By Nasdaq GlobeNewswire

Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update

09 May 2024 16:01:28 By Nasdaq GlobeNewswire

Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine

06 May 2024 11:16:04 By Nasdaq GlobeNewswire